Celanese Corporation
General ticker "CE" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $6.0B (TTM average)
Celanese Corporation follows the US Stock Market performance with the rate: 5.6%.
Estimated limits based on current volatility of 2.4%: low 40.82$, high 42.85$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-10-28, amount 0.03$ (Y0.30%)
- Total employees count: 12163 as of 2024
- China accounted for 19.3% of revenue in the fiscal year ended 2024-12-31
- US accounted for 26.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Supply chain disruptions, Cybersecurity threats, Economic downturns and volatility, Product liability
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [36.80$, 77.97$]
- 2025-12-31 to 2026-12-31 estimated range: [34.21$, 67.90$]
Financial Metrics affecting the CE estimates:
- Negative: with PPE of 8.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Industry operating cash flow per share per price (median), % of 12.62 > 10.33
- Positive: 6.82 < Operating cash flow per share per price, % of 12.91
- Positive: 18.93 < Shareholder equity ratio, % of 22.64 <= 41.86
- Negative: negative Net income
- Positive: 0 < Industry earnings per price (median), % of 2.47
Short-term CE quotes
Long-term CE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $9,677.00MM | $10,940.00MM | $10,280.00MM |
| Operating Expenses | $8,299.00MM | $9,253.00MM | $10,977.00MM |
| Operating Income | $1,378.00MM | $1,687.00MM | $-697.00MM |
| Non-Operating Income | $43.00MM | $-504.00MM | $-299.00MM |
| Interest Expense | $405.00MM | $720.00MM | $676.00MM |
| R&D Expense | $112.00MM | $146.00MM | $130.00MM |
| Income(Loss) | $1,421.00MM | $1,183.00MM | $-996.00MM |
| Taxes | $-489.00MM | $-790.00MM | $510.00MM |
| Other Income(Loss) | $-8.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $1,894.00MM | $1,960.00MM | $-1,522.00MM |
| Stockholders Equity | $5,637.00MM | $7,091.00MM | $5,175.00MM |
| Inventory | $2,808.00MM | $2,357.00MM | $2,284.00MM |
| Assets | $26,272.00MM | $26,597.00MM | $22,857.00MM |
| Operating Cash Flow | $1,819.00MM | $1,899.00MM | $966.00MM |
| Capital expenditure | $543.00MM | $568.00MM | $435.00MM |
| Investing Cash Flow | $-11,141.00MM | $-134.00MM | $-470.00MM |
| Financing Cash Flow | $10,290.00MM | $-1,456.00MM | $-1,313.00MM |
| Earnings Per Share** | $17.48 | $18.01 | $-13.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.